van Osch G J, ten Koppel P G, van der Veen S W, Poppe P, Burger E H, Verwoerd-Verhoef H L
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, Rotterdam, The Netherlands.
Biomaterials. 1999 Feb;20(3):233-40. doi: 10.1016/s0142-9612(98)00165-3.
The use of a composite graft of bovine trabecular demineralized bone matrix (DBM) and perichondrium has been found a reliable method for in vivo generation of cartilage. In the present study, the mechanism whereby this commercially available matrix increases cartilage formation was investigated. First, the time course of cartilage formation in vivo, in the combined implant of perichondrium and DBM in the rabbit ear was studied, with special focus on tissue reactions to DBM. DBM was colonized by macrophages from day 3 post-operatively, reaching a maximum after 2 weeks. Only a minimal number of neutrophils was found. After 3 weeks the DBM appeared to be resorbed. In the first week the DBM was invaded with chondroblasts, and chondrogenesis occurred between the first and second week of implantation. After 3 weeks, the initially formed islets of cartilage had fused. Next, the chondrogenic capacity of DBM itself was investigated by implantation of DBM without perichondrium. This never resulted in cartilage formation. Immunohistochemistry showed only a faint staining of the DBM for growth factors. This indicates a minimal chondrogenic effect of DBM alone and the requirement of perichondrium as cell provider. In order to define the conditions which cause chondrogenesis in composites of perichondrium and DBM, a series of in vitro culture experiments was performed in which the in vivo situation was mimicked step by step. The basic condition was perichondrium cultured in medium with 10% FCS. In this condition, cartilage formation was variable. Because in the in vivo situation both DBM and macrophages can release growth factors, the effect of IGF1, TGFbeta2 or OP1 added to the culture medium was tested. Neither the incidence nor the amount of cartilage formation was stimulated by addition of growth factors. Perichondrium wrapped around DBM in vitro gave cartilage formation in the perichondrium but the incidence and amount were not significantly stimulated compared to cultures of perichondrium without DBM. However, cartilage-like cells were found in the DBM suggesting an effect of DBM on perichondrium-derived cells. Finally, macrophages and/or blood were added to the composite DBM-perichondrium to mimic the in vivo situation as close as possible. However, no effect of this treatment was found. In conclusion, this study indicates that DBM itself has few chondrogenic qualities but functions merely as a spacer for cell ingrowth. The fast resorption of DBM by macrophages in vivo seems of importance for the cartilage forming process, but in vitro the presence of macrophages (in combination with blood) could not enhance chondrogenesis.
已发现使用牛小梁脱矿骨基质(DBM)和软骨膜的复合移植物是一种在体内生成软骨的可靠方法。在本研究中,对这种市售基质增加软骨形成的机制进行了研究。首先,研究了兔耳软骨膜和DBM联合植入物在体内软骨形成的时间进程,特别关注对DBM的组织反应。术后第3天巨噬细胞开始在DBM上定植,2周后达到高峰。仅发现极少量的中性粒细胞。3周后DBM似乎被吸收。在第一周,成软骨细胞侵入DBM,在植入后的第一周和第二周发生软骨形成。3周后,最初形成的软骨岛融合。接下来,通过植入无软骨膜的DBM来研究DBM本身的软骨形成能力。这从未导致软骨形成。免疫组织化学显示DBM对生长因子仅有微弱染色。这表明单独的DBM软骨形成作用极小,且需要软骨膜作为细胞提供者。为了确定在软骨膜和DBM复合物中导致软骨形成的条件,进行了一系列体外培养实验,逐步模拟体内情况。基本条件是在含10%胎牛血清的培养基中培养软骨膜。在这种条件下,软骨形成情况不一。因为在体内情况下DBM和巨噬细胞都能释放生长因子,所以测试了向培养基中添加胰岛素样生长因子1(IGF1)、转化生长因子β2(TGFβ2)或骨形态发生蛋白1(OP1)的效果。添加生长因子既未刺激软骨形成的发生率,也未刺激其形成量。体外将软骨膜包裹在DBM周围,软骨膜中出现了软骨形成,但与无DBM的软骨膜培养物相比,其发生率和形成量并未受到显著刺激。然而,在DBM中发现了软骨样细胞,提示DBM对源自软骨膜的细胞有作用。最后,将巨噬细胞和/或血液添加到DBM - 软骨膜复合物中以尽可能接近地模拟体内情况。然而未发现这种处理有效果。总之,本研究表明DBM本身几乎没有软骨形成特性,仅作为细胞向内生长的间隔物起作用。巨噬细胞在体内对DBM的快速吸收似乎对软骨形成过程很重要,但在体外巨噬细胞(与血液一起)的存在并不能增强软骨形成。